Scarica l'app Stockscreener
1.91
0.79%
0.015
Pre-mercato:
1.95
0.04
+2.09%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLS Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.895
Aprire:
$1.93
Volume 24 ore:
1.93M
Relative Volume:
0.89
Capitalizzazione di mercato:
$201.12M
Reddito:
-
Utile/perdita netta:
$-37.34M
Rapporto P/E:
-1.4044
EPS:
-1.36
Flusso di cassa netto:
$-36.91M
1 W Prestazione:
+2.14%
1M Prestazione:
+1.60%
6M Prestazione:
+72.07%
1 anno Prestazione:
+59.17%
Intervallo 1D:
$1.8501
$1.93
Intervallo di 1 settimana:
$1.81
$1.95
Portata 52W:
$0.772
$2.2691
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
Nome
Sellas Life Sciences Group Inc
Settore
Industria
Telefono
(646) 200-5278
Indirizzo
7 TIMES SQUARE, NEW YORK, NY
Confronta SLS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
1.91 | 236.84M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-07-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-11-01 | Iniziato | Oppenheimer | Outperform |
| 2018-04-02 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-19 | Aggiornamento | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc Borsa (SLS) Ultime notizie
Quantitative breakdown of SELLAS Life Sciences Group Inc. recent move2025 Short Interest & Verified Short-Term Trading Plans - newser.com
How institutional ownership impacts SELLAS Life Sciences Group Inc. stockEarnings Risk Report & Stepwise Trade Execution Plans - newser.com
Published on: 2025-10-13 00:27:53 - newser.com
Smart tools for monitoring SELLAS Life Sciences Group Inc.’s price actionWeekly Trade Summary & Low Risk Growth Stock Ideas - newser.com
How SELLAS Life Sciences Group Inc. stock valuations compare to rivals2025 Major Catalysts & Real-Time Volume Spike Alerts - newser.com
What data driven models say about SELLAS Life Sciences Group Inc.’s futureMarket Trend Review & Weekly Momentum Stock Picks - newser.com
Using data models to predict SELLAS Life Sciences Group Inc. stock movementJuly 2025 Decliners & Precise Entry and Exit Recommendations - newser.com
What analyst consensus says on SELLAS Life Sciences Group Inc. stock2025 Momentum Check & Weekly Sector Rotation Insights - newser.com
How to integrate SELLAS Life Sciences Group Inc. into portfolio analysis toolsPortfolio Performance Report & High Return Trade Guides - newser.com
Using R and stats models for SELLAS Life Sciences Group Inc. forecastingExit Point & Expert Approved Momentum Ideas - newser.com
Published on: 2025-10-09 03:27:21 - newser.com
Published on: 2025-10-09 03:07:14 - newser.com
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Sees Significant Decrease in Short Interest - Defense World
Multi factor analysis applied to SELLAS Life Sciences Group Inc.July 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com
Using Python tools to backtest SELLAS Life Sciences Group Inc. strategies2025 Dividend Review & Free Accurate Trade Setup Notifications - newser.com
Can SELLAS Life Sciences Group Inc. (RXK3) stock double in coming years2025 Short Interest & Stock Market Timing Techniques - newser.com
Published on: 2025-10-06 05:59:31 - newser.com
SELLAS Extends Times Square Sublease Agreement - TipRanks
Why SELLAS Life Sciences Group Inc. (RXK3) stock benefits from AI revolutionEarnings Risk Summary & Community Consensus Picks - newser.com
Published on: 2025-10-03 03:10:59 - newser.com
Chart based analysis of SELLAS Life Sciences Group Inc. trendsJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Is SELLAS Life Sciences Group Inc. stock bottoming out2025 Buyback Activity & Daily Profit Focused Screening - newser.com
Published on: 2025-10-02 22:11:46 - newser.com
Will SELLAS Life Sciences Group Inc. (RXK3) stock test record highs in 20252025 Volume Leaders & High Conviction Investment Ideas - newser.com
SELLAS Life Sciences Group to Host Virtual R&D Day on October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 Program Update - Sahm
SELLAS Life Sciences to host virtual R&D day on AML treatments - Investing.com Nigeria
How Product Roadmap Could Affect Music Broadcast Limiteds Future ValueResistance Zone Identification & Free Stock Education Platform for New Investors - earlytimes.in
SELLAS Life Sciences to host virtual R&D day on AML treatments By Investing.com - Investing.com South Africa
What drives SELLAS Life Sciences Group Inc RXK3 stock priceHigh Beta Stocks & Fast Growing Investment Plans - earlytimes.in
SELLAS Life Sciences Group to Host Virtual R&D Day on - GlobeNewswire
Major AML Treatment Updates: SELLAS Life Sciences to Reveal Phase 3 REGAL Results & New Drug Progress - Stock Titan
Published on: 2025-09-30 01:16:34 - newser.com
What high frequency data says about SELLAS Life Sciences Group Inc.Market Activity Recap & Weekly Momentum Picks - newser.com
Published on: 2025-09-29 11:38:19 - newser.com
Published on: 2025-09-29 09:42:54 - newser.com
SELLAS Life Sciences Group Inc RXK3 Stock Analysis and ForecastMomentum Stock Picks & Budget Friendly Growth - earlytimes.in
What drives Deere Company stock priceSector Performance Drivers & Boost Wealth With Growth - earlytimes.in
Can SELLAS Sustain Momentum As GPS Nears Final Readout And SLS009 Moves Forward? - RTTNews
Profit Review: What is the target price for OTIS stockMarket Performance Report & Stepwise Trade Execution Plans - خودرو بانک
Sellas Life Sciences Group Inc Azioni (SLS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sellas Life Sciences Group Inc Azioni (SLS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wasman Jane | Director |
May 30 '25 |
Buy |
1.69 |
20,000 |
33,800 |
30,400 |
| Kalin Katherine Bach | Director |
May 22 '25 |
Buy |
1.80 |
20,000 |
36,000 |
41,000 |
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):